moclobemide has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 3 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic fatigue syndrome is characterized by prolonged and disabling fatigue and a range of neuropsychiatric symptoms including depressed and/or irritable mood." | 2.69 | A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. ( Bennett, BK; Hickie, IB; Lloyd, AR; Wakefield, D; Wilson, AJ; Wright, JM, 2000) |
| " We studied the efficacy and adverse effects of moclobemide in patients with chronic fatigue syndrome, stratifying the sample both by co-morbid major depressive illness and by sleep disturbance." | 2.68 | An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome. ( Cleary, KJ; White, PD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hickie, I | 1 |
| Wilson, A | 1 |
| White, PD | 1 |
| Cleary, KJ | 1 |
| Hickie, IB | 1 |
| Wilson, AJ | 1 |
| Wright, JM | 1 |
| Bennett, BK | 1 |
| Wakefield, D | 1 |
| Lloyd, AR | 1 |
2 trials available for moclobemide and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome.
Topics: Adult; Benzamides; Depressive Disorder; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged | 1997 |
A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.
Topics: Adult; Comorbidity; Depressive Disorder; Double-Blind Method; Fatigue Syndrome, Chronic; Female; Hum | 2000 |
1 other study available for moclobemide and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
A catecholamine model of fatigue.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Benzamides; Brain; Catecholamines; Depressive D | 1994 |